Considered the founder of the industry, Ionuvox, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years.
Ionuvox is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Company Details
- Founded
- 2009
- Address
- Empire State Building, New York,india
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.ionuvox.com
- HQ
- New York, New York
Ionuvox Research And Development Questions
Ionuvox Research And Development's website is http://www.ionuvox.com
Ionuvox Research And Development's LinkedIn profile is https://www.linkedin.com/company/ionuvox-research-and-development
Ionuvox Research And Development's industry is
Research Services
Ionuvox Research And Development's top competitors are
Bridge Medicines Llc,
Micoy Therapeutics,
Dave Cantin Group,
Grit Bio, Inc.,
Os Therapies,
Concarlo Therapeutics,
Blood Cell Technologies,
Sparian Biosciences,
Chemitope Glycopeptide, Inc.,
Novita Pharmaceuticals.
Ionuvox Research And Development's categories are Research Services
Ionuvox Research And Development's founding year is 2009
